Composition for Treating Hyperlipaemia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 28, 2008
app pub date -
Apr 29, 2005
filing date -
Apr 30, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention provides a composition for treating hyperlipemia, which comprises the first active component acipimox, and the second active component atorvastatin, or the pharmaceutically acceptable salt, ester or solvate thereof. Weight ratio of the first to the second active component is (10-80):1. The composition is in the form of tablets, capsules, granules, pills or dropping pills. The combination of acipimox and atorvastatin is shown to have remarkably synergistic effect in decreasing serum total cholesterol, serum triglyceride and low density lipoprotein-cholesterol. Furthermore, in comparison with the combination of acipimox and pravastatin or the combination of acipimox and lorvastatin, the combination of acipimox and atorvastatin is shown to have more remarkable lipid decreasing effect, and have more advantageous effect of increasing high density lipoprotein-cholesterol.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully